|
End-of-day quote
SPOTLIGHT STOCK MARKET AB
2026-08-12
|
5-day change | 1st Jan Change | ||
| 0.6200 SEK | -5.20% |
|
-1.27% | +3.33% |
| 08-11 | Acucort's phase IV study with Zeqmelit published | FW |
| 08-11 | Acucort Publishes Results from Phase Iv Study with Zeqmelit Oral Film | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACUCORT AB | Other Drug Retailers | -5.20% | -1.27% | +3.33% | -5.34% | -85.84% | 15.22M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ACUC Stock
- Charts AcuCort AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
